Skip to main content
Industry News
Coronavirus vaccine triggers immune response in animals

A low dose of an experimental messenger-RNA-based SARS-CoV-2 vaccine triggered an immune response in animals, and studies in people might start next month, says German biotech firm CureVac. The technology is similar to that used in a vaccine from Moderna, which reported preliminary results from studies in mice and humans this week.

Full Story: